Tom Frohlich, Chief Operating Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 9,132 shares at $24.68 ($225K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Open-market sale of $225k KDNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.68 | 4,566 | $113K | 50.0% |
| 2 | $24.68 | 4,566 | $113K | 50.0% |
| Total | $24.68 avg | 9,132 | $225K | 100% |
| Filing → |
| KDNY | SELL | 2022-12-15 | $250K | — | Filing → |
| KDNY | SELL | 2022-11-09 | $222K | — | Filing → |
| KDNY | SELL | 2022-10-11 | $290K | — | Filing → |